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Abstract: Herbomineral formulations are used extensively in the world-wide for the prevention and treatment of a wide range of 
disorders. A new proprietary herbomineral formulation was formulated consisted of an ashwagandha root extract and minerals (zinc, 
magnesium, and selenium). The present study was aimed to evaluate the impact of the Biofield Energy Treated herbomineral 
formulation in male Sprague Dawley (SD) rats for immune biomarkers modulation. The test formulation was divided into two parts. 
One part was denoted as the control without any Biofield Energy Treatment, while the other part was defined as the Biofield Energy 
Treated sample, which received the Biofield Energy Healing Treatment remotely from twenty renowned Biofield Energy Healers. 
The experimental parameters studies were humoral immune response (primary and secondary titre), delayed type hypersensitivity 
reaction, animal weight parameters, feed and water intake, histopathology, hematological and serum biochemistry. The humoral 
immune response exhibited that both the primary and secondary hemagglutination (HA) antibody titre levels were significantly 
altered by 14.79% and 12.89%, respectively in the Biofield Energy Treated test formulation group (G4) compared to the disease 
control group (G2). The delayed type hypersensitivity (DTH) response was significantly (p≤0.05) increased by 55.56% in the G4 
group compared to the G2 group. The hematological results revealed that the platelet count was significantly increased by 8.46% in 
the G4 group with respect to the G2 group. Moreover, the level of phosphorus was significantly increased by 11.16% and 16.35% in 
the levamisole (G3) and G4 groups, respectively compared to the G2 group. In conclusion, the Biofield Energy Treated Test 
Formulation would be the powerful immunomodulatory product, which was found safe at the tested doses. Therefore, The Trivedi 
Effect
®
-Biofield Energy Healing based herbomineral formulation can be applied to potentiate the immune system that helps to fight 
against many infectious diseases. Overall, these data suggest that the Biofield Energy Treated test formulation can be used for 
autoimmune and inflammatory diseases, stress management and prevention, and anti-aging by improving overall health. 
Keywords: Biofield Energy Healing, Immunomodulation, Herbomineral Formulation, Humoral Immune Response, 
Antibody Titre, Delay Type Hypersensitivity, Stress Management and Anti-aging 
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1. Introduction 
Most of the world’s population depends upon the 
traditional medicine as the main source of treatment. In 
developed and developing countries alike, medicinal plant-
derived drugs are continuously gaining popularity due to 
their natural origin and low side effects. Indigenous plants 
play an important role against various common ailments 
and chronic diseases [1]. Some medicinal plants are 
believed to be useful to strengthen the human immune 
system [2], while such plant based formulations play an 
important role with significant effect in the modern health 
care system [3]. A global reliance on alternative system of 
medicine for any types of ailments resulted in an intense 
area of research and discovery of a number of herbs and 
minerals with their potential to cure diseases [4]. 
Immunomodulation is a process, in which an organism can 
homeostat the immune response by either stimulation or 
suppression of immune system in the cells and organs [4, 
5]. The Complementary and Alternative Medicine (CAM) 
has increased globally for the treatment and prevention of 
many chronic diseases in human population [6]. Number of 
herbs and minerals have been exploited for modulation of 
immune system from Ayurvedic formulation. Likewise, an 
herbomineral formulation was designed. The herbal 
remedies are amongst the most prevalent therapies due to 
lack of adverse effects and low cost [7]. The newly 
formulated herbomineral formulation, which was a 
combination of ashwagandha root extract along with trace 
elements such as zinc chloride, magnesium gluconate 
hydrate, and sodium selenate for immunomodulatory 
activity. Each constituent of this formulation commonly 
used as nutraceutical supplement [8-11]. Herbomineral 
formulations are reported to improve the general health by 
increasing the body’s immunity. Numerous scientific 
reports and clinical trials had evident for the beneficial 
effect of Biofield Energy Treatment on immune system 
such as preservation of immune function in cervical cancer 
patients after therapeutic touch [12], massage therapy in 
enhancing immune system [13], and many more. The 
National Center for Complementary/Alternative Medicine 
(NCCAM) has described and given priority to the energy 
therapies, as it works by manipulating the energy fields that 
theoretically surround and penetrate the body [14]. 
In recent years, several scientific reports and clinical 
trials have revealed the useful effects of the Biofield Energy 
Treatment, which has shown enhanced immune function in 
cases of cervical cancer patients with therapeutic touch 
[12], massage therapy [13], etc. Complementary and 
Alternative Medicine (CAM) therapies are now rising as 
preferred models of treatment, among which Biofield 
Therapy (or Healing Modalities) is one approach that has 
been reported to have several benefits to enhance physical, 
mental and emotional human wellness. However, as per the 
data of 2012 from the National Health Interview Survey 
(NHIS), which comprised that the highest percentage 
(17.7%) of the Americans used dietary supplement as 
complementary health approaches as compared with other 
practices in past years. The National Center of 
Complementary and Integrative Health (NCCIH) has 
recognized and accepted Biofield Energy Healing as a 
CAM health care approach in addition to other therapies, 
medicines and practices such as natural products, deep 
breathing, yoga, Tai Chi, Qi Gong, chiropractic/osteopathic 
manipulation, meditation, massage, special diets, 
homeopathy, progressive relaxation, guided imagery, 
acupressure, acupuncture, relaxation techniques, 
hypnotherapy, healing touch, movement therapy, pilates, 
rolfing structural integration, mindfulness, Ayurvedic 
medicine, traditional Chinese herbs and medicines, 
naturopathy, essential oils, aromatherapy, Reiki, and cranial 
sacral therapy. Human Biofield Energy has subtle energy 
that has the capacity to work in an effective manner [15]. 
CAM therapies have been practiced worldwide with 
reported clinical benefits in different health disease profiles 
[16]. This energy can be harnessed and transmitted by 
individuals into living and non-living things via the process 
of Biofield Energy Healing. Biofield Energy Treatment 
(The Trivedi Effect
®
) has been published in numerous peer-
reviewed science journals with significant outcomes in 
many scientific fields such as cancer research [17, 18], 
microbiology [19-22], genetics [23, 24], pharmaceutical 
science [25-28], agricultural science [29-32], and materials 
science [33-36]. 
The authors sought to evaluate the impact of the Biofield 
Energy Treatment (The Trivedi Effect
®
) on the test 
herbomineral formulation for immunomodulatory action with 
respect to antibody titre, delayed type hypersensitivity 
reaction, body weight change, feed consumption, 
hematological parameters, and serum biochemistry using 
standard assays. 
2. Materials and Methods 
2.1. Chemicals and Reagents 
Cyclophosphamide and sodium carboxymethyl cellulose 
were obtained from Sigma Chemical Co. (St. Louis, MO). 
Ashwagandha (Withania somnifera) root extract was 
purchased from Sanat Products Ltd., India. Zinc chloride and 
magnesium (II) gluconate hydrate were obtained from TCI, 
Japan. Sodium selenate was procured from Alfa Aesar, USA. 
Levamisole hydrochloride was procured from Sigma, USA. 
All other chemicals used in this study were analytical grade 
available in India. 
2.2. Laboratory Animals 
Randomly breed male Sprague Dawley (SD) rats with 
body weight ranges between 237 to 286 gm were used in this 
experiment. The animals were purchased from M/s. Vivo Bio 
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Tech Ltd., Hyderabad, India. Standard rodent diet was 
procured from M/s. Golden feeds, Mehrauli, New Delhi, 
India and provided ad libitum to all the groups of animals 
during the experiment under controlled conditions with a 
temperature of 22 ± 3°C, humidity of 30% to 70% and a 12-
hour light/12-hour dark cycle. The animals were acclimatized 
for the period of 5 days prior to the experiment, and all were 
accessed once daily for clinical signs, behaviors, morbidity 
and mortality. All the procedures were in strict accordance 
with the Guide for the Care and Use of Laboratory Animals 
published by the US National Institutes of Health. The 
approval of the Institutional Animal Ethics Committee was 
obtained prior to carrying out the animal experiment. 
2.3. Energy of Consciousness Treatment Strategies 
The test formulation was divided into two parts. One part 
of the test formulation was treated with Biofield Energy by 
renowned Biofield Energy Healers (also known as The 
Trivedi Effect
®
) and coded as the Biofield Energy Treated 
formulation, while the second part of the test formulation did 
not receive any sort of treatment and was defined as the 
untreated test formulation. This Biofield Energy Treatment 
was provided through a group of twenty Biofield Energy 
Healers who participated in this study and performed the 
Biofield Energy Treatment remotely. Thirteen Biofield 
Energy Healers were remotely located in the U.S.A., five 
were located in Canada, and two were located in Australia, 
while the test herbomineral formulation was located in the 
research laboratory of Dabur Research Foundation, New 
Delhi, India. This Biofield Energy Treatment was 
administered for 5 minutes through the Healer’s unique 
Energy Transmission process remotely to the test formulation 
under laboratory conditions. None of the Biofield Energy 
Healers in this study visited the laboratory in person, nor had 
any contact with the herbomineral samples. Further, the 
control group was treated with a “sham” healer for 
comparative purposes. The sham healer did not have any 
knowledge about the Biofield Energy Treatment. After that, 
the Biofield Energy Treated and untreated samples were kept 
in similar sealed conditions and used for identification of 
immunological parameters. 
2.4. Antigen (Sheep RBC, sRBC) 
The fresh sheep blood was collected aseptically from the 
jugular vein of a healthy sheep and transferred immediately 
to the heparinized tube. The collected erythrocytes were 
separated from plasma by centrifugation (400 g, 10°C, 10 
minutes), washed twice with the normal saline and then 
further diluted in saline, which were analyzed using a 
Hematology analyzer (Abbott Model-CD-3700). Based on 
the number of erythrocytes, the samples were further diluted 
(using saline) before injecting to the rat [37]. 
2.5. Experimental Procedure 
The animals were randomized and grouped according to 
their body weight. A total of five groups (G) were included 
i.e. Group 1 (G1) was served as a normal control (i.e. 
vehicle control), and G2 was served as a disease control; 
both the groups were received 0.5% Na-CMC, while G3 
group animals received levamisole at 75 mg/kg per oral 
(p.o.). G4 group animals were received Biofield Energy 
Treated test formulation at a dose of 1105.005 mg/kg. 
Similarly, G5 animals were received untreated test 
formulation at a same dose. However, during the 
experimental period, all the animals except normal control 
(G1) were received with cyclophosphamide (10 mg/kg, 
p.o.) daily to induce the immunosuppression action. 
Cyclophosphamide was given 1 hour prior to the oral 
administration of test formulation for initial period of 13 
days. The treatment was continued to all the tested groups 
(G1 to G5) with 5 mL/kg body weight dose volume for 22 
day experiment. Further, on day 7 and 13, all the groups 
(G1 to G5) received sRBC (0.5 X 10
9
/100 gm body weight; 
i.p.). On day 13 and 20, blood was withdrawn from retro 
orbital plexus under isoflurane anesthesia and the serum 
was separated for hemagglutination assay. On day 20, the 
animals were challenged with sRBC (0.5 X 10
9
 cells/100 
µL/rat) in right paw, while on day 21 and 22, the paw 
thickness was measured using micrometer (MITUTOYO, 
Japan). The body weight, food intake, and water intake 
were measured daily before the treatment. On day 22, the 
animals were kept under overnight fasting and on day 23 
blood was withdrawn from retro orbital plexus under 
isoflurane anesthesia. At the end of the study; animals were 
euthanized by CO2 asphyxiation as per in-house approved 
standard protocol. Different organs of all animals were 
excised, weighed and preserved for histopathological 
analysis. 
2.6. Hemagglutination Antibody Titre 
Approximately 25 µL of serum was serially diluted with 
the 25 µL of phosphate-buffered saline. The sRBC (0.025 x 
10
9
 cells) was added to each of these dilutions and incubated 
at 37°C for 1 hour. The rank of minimum dilution that 
exhibited hemagglutination was considered as an antibody 
titre. The level of antibody titre on day 13 of the experiment 
was considered as the “primary humoral immune response” 
and the day 20 was considered as the “secondary humoral 
immune response” [38, 39]. 
2.7. Determination of Paw Volume (Delayed Type 
Hypersensitivity) 
The cellular immune response was assayed by the footpad 
reaction method. The edema was induced in the right paw of 
rats by injecting sRBC (0.5 x 10
9
 cells) in the sub-plantar 
region. The increase in the paw thickness in 24 and 48 hours, 
i.e. on day 21 and 22 was assessed using a micrometer 
(MITUTOYO, Japan). The thickness of the left hind paw, 
injected similarly with normal saline, served as control. The 
mean percentage increase in paw thickness in comparison to 
control was considered as a delayed type of hypersensitivity 
and as an index of cell-mediated immunity [40]. 
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2.8. Determination of Hematological and Biochemical 
Parameters 
After fasting for 12 to 16 hours, blood was collected from 
the retro-orbital plexus using heparinized or non-heparinized 
capillary tubes. One portion of the blood was kept in plain 
bottles from which serum was collected and stored for 
biochemical analysis. The other portion was directly 
subjected for the estimation of various hematological 
parameters using standard instruments. The levels of 
hemoglobin (Hb), red blood cell count (RBC), packed cell 
volume (PCV), mean corpuscular volume (MCV), mean 
corpuscular hemoglobin (MCH), mean corpuscular 
hemoglobin concentration (MCHC) and platelets were 
analyzed in the blood samples in all experimental groups. 
Further, the levels of magnesium, blood urea, creatinine, uric 
acid, calcium, phosphorus, potassium, sodium, and chloride 
ion concentration were analyzed using Hematology analyzer 
(Abbott Model-CD-3700) [41]. 
2.9. Determination of Body Weight, Feed Intake and Water 
Intake 
The body weight, feed intake, and water intake were 
measured once daily before the test item administration 
throughout the experiment. In brief, the weight of the daily 
feed intake was calculated from the difference between the 
weight of daily feed supply and the left-over feed was taken 
as the daily feed intake [42]. 
2.10. Clinical Sign and Symptoms 
The clinical signs and symptoms were observed once daily 
in all the groups as per in-house standard protocol throughout 
the experiment. Animals found in a moribund condition or 
enduring signs of severe distress was humanely euthanized 
[43]. 
2.11. Measurement of Relative Organ Weight and 
Histopathology 
At the end of the study; animals were euthanized by CO2 
asphyxiation as per in-house standard protocol. Different 
organs of all animals were excised, weighed and preserved 
for histopathological analysis viz. the whole liver, lungs, 
kidneys, brain, hearts, eyes, spleens, duodenum, jejunum, 
ileum, caecum, colon, rectum, testis, prostate, epididymis, 
vas-deference, and pancreas. In brief, the organs were 
trimmed off for any adherent tissue and fat, as appropriate 
and were weighed wet as soon as possible to avoid drying. 
The organ to body weight ratio of each rat was determined by 
comparing the absolute weight of each organ with the final 
body weight. The collected tissues were placed in 10% 
neutral buffered formalin for histopathological examination. 
Eyes and testis were fixed in Davidson’s fixative and 
modified Davidson fluid, respectively for 24 hour and 
followed by 70% alcohol for 48 hour. After that, all the 
organs were subjected to histopathology as per standard 
protocol [44, 45]. 
Relative organ weight was calculated using the formula 
mentioned below- 
Relative	organ	weight
= Absolute	organ	weight(g)
/weight	of	rat	on	sacrifice	day(g)X100 
2.12. Statistical Analysis 
Sigma-plot (v11.0) was used for all statistical analysis. 
Data are presented as mean ± standard error of mean (SEM) 
and analyzed by Student’s t-test; p≤0.05 was considered 
statistically significant. 
3. Results and Discussion 
3.1. Effect of the Test Formulation on Humoral Immune 
Response 
The antigen-antibody reaction results in agglutination. 
The relative strength of an antibody titre is defined as the 
reciprocal of the highest dilution, which is still capable of 
causing visible agglutination. The antibody titre is a useful 
tool to measure the changes in the amount of the antibody 
in the course of an immune response [6]. The primary and 
secondary humoral immune responses after oral 
administration of the test formulation in male Sprague 
Dawley rats are shown in the Table 1. Both the primary 
and secondary responses of mean hemagglutination (HA) 
antibody titre were significantly (p≤0.001) decreased by 
66.20% and 66.25% in the disease control group (G2) 
compared to the normal control group (G1). It was 
indicated that cyclophosphamide remarkably suppressed 
the immunoresponse as evident by lowered the level of 
both primary and secondary titres. The primary and 
secondary HA titre levels were suppressed by 14.79% and 
12.89%, respectively in the Biofield Energy Treated test 
formulation group (G4) compared to the G2 group. 
Besides, both the primary and secondary HA titre levels 
were raised significantly by 47.93% and 74.07%, 
respectively in the untreated test formulation group (G5) 
compared to the G2 group. It was indicated that the 
Biofield Energy Treated test formulation showed 
immunosuppressive response in comparison with the 
disease control group (G2). It is assumed that the 
decreased levels of both primary and secondary antibody 
titre in the Biofield Energy Treated test formulation group 
(G4) might be due to Biofield Energy Healing through 
Biofield Energy Transmission to the test formulation. In 
contrary, the primary HA titre response was significantly 
raised by 25.74%, while the secondary response was 
reduced minimally in the levamisole group (G3) compared 
to the disease control (G2). It is presumed that the 
Biofield Energy Treated herbomineral formulation possess 
potential immunomodulatory activities. 
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Table 1. Effect of the test formulation on hemagglutination (HA) antibody 
titre using sRBC as an antigen in male Sprague Dawley rats. 
Group Primary HA titre Secondary HA titre 
G1 10.00 ± 1.31 20.00 ± 2.62 
G2 3.38 ± 0.78*** 6.75 ± 3.70* 
G3 4.25 ± 0.59 6.50 ± 3.73 
G4 2.88 ± 0.79 5.88 ± 1.85 
G5 5.00 ± 1.73 11.75 ± 4.72 
Values are expressed as mean ± SEM, n=8 in each group. The primary 
response of mean hemagglutination (HA) antibody titre value was recorded 
on day 13th and secondary response on day 20th of the experimental period. 
G: Group; G1: Normal control; G2: Disease control; G3: Reference item 
(Levamisole); G4: Biofield Energy Treated test formulation; G5: Untreated 
test formulation. *p≤0.05 and ***p≤0.001 vs normal control. 
3.2. Estimation of Delayed Type Hypersensitivity (Paw 
Volume) 
The effect of the test formulation on delayed type 
hypersensitivity (DTH) response sRBC was injected in paw 
(sub-plantar) and paw thickness was measured at 24 and 48 
hours after post injection is shown in the Figure 1. The paw 
thickness was significantly decreased by 29.69% at 24 hours; 
while it was increased by 53.57% at 48 hours in the disease 
control group (G2) compared to the normal control (G1). The 
paw thickness was significantly (p≤0.05) increased by 
55.56% in the Biofield Energy Treated test formulation (G4) 
at 24 hours; however paw thickness was unaltered at 48 
hours compared to the G2 group. In the early hypersensitivity 
reaction, the antigen-antibody forms immune complexes, 
which are known to induce local inflammation with increased 
vascular permeability and edema [6]. Naik et al. (2015) 
documented that ashwagandha increased the animal paw 
thickness [46], moreover zinc was also reported to increase 
the DTH reaction [47]. Therefore, it can be concluded that 
the constituents present in this formulation are responsible 
for DTH reaction. The Biofield Energy Treated (The Trivedi 
Effect
®
) test formulation (G4) showed better cellular immune 
response compared with the untreated test formulation (G5). 
 
Figure 1. Effect of the test formulation on paw thickness (delayed type hypersensitivity) in Sprague Dawley rats. G1: Normal control; G2: Disease control: 
G3: Levamisole; G4: Biofield Energy Treated test formulation; G5: Untreated test formulation. All the values are expressed as the mean ± SEM (n = 8). 
*p≤0.05 vs disease control. 
3.3. Effect of the Test Formulation on Hematological 
Parameters 
The effect of the test formulation on hematological 
parameters is shown in the Table 2. Results showed the 
platelet count was significantly increased by 8.46% and 
1.54% in the Biofield Energy Treated test formulation group 
(G4) and untreated test formulation group (G5), respectively 
with respect to the disease control group (G2). It was 
indicated that the Biofield Energy Treated test formulation 
group showed more increment of platelets counts compared 
to the untreated test formulation group; which might be due 
to the Biofield Energy Healing Treatment. Moreover, the 
platelet count was increased by 6.15% in the levamisole 
group (G3) compared to the G2. Overall, it was indicated that 
the Biofield Energy Treated test formulation improved the 
platelet counts compared to the both G2 and G5 groups. 
From the literature, it was reported that ashwagandha 
prevented myelosuppression and increased in the platelet 
count and body weight [48, 49]. Our experimental finding 
showed increased platelet count, which could be due to 
Biofield Energy Healing Treatment to the test formulation. 
Rest of the parameters such as RBC, Hb, MCHC, PCV, MCV 
and MCH were altered minimally compared to the G2 group. 
It is assumed that these parameters were unaffected by the 
Biofield Energy Treatment. 
Table 2. Evaluation of hematology parameters after treatment with the test formulation in experimental rat. 
Group 
RBC 
(106/	L) 
Hb 
(gm/dL) 
PCV 
(%) 
MCV 
(fl) 
MCH 
(pg) 
MCHC 
(%) 
Platelet Count 
(thou/mm3) 
RDW-CV 
G1 10.16 ± 0.30 17.55 ± 0.51 59.89 ± 1.83 58.94 ± 0.69 17.24 ± 0.18 29.29 ± 0.43 793.75 ± 68.42 0.14 ± 0.00 
G2 9.49 ± 0.30 16.93 ± 0.55 58.06 ± 1.73 61.34 ± 1.03 17.79 ± 0.15 29.13 ± 0.30 812.50 ± 67.31 0.15 ± 0.00 
G3 8.61 ± 0.12 15.04 ± 0.16 50.81 ± 0.76 59.14 ± 0.59 17.44 ± 0.16 29.56 ± 0.39 862.50 ± 54.89 0.15 ± 0.00 
G4 8.81 ± 0.36 15.74 ± 0.25 53.51 ± 0.69 58.33 ± 0.58 17.13 ± 0.38 29.44 ± 0.40 881.25 ± 79.02 0.14 ± 0.00 
G5 9.00 ± 0.19 15.94 ± 0.39 53.20 ± 1.35 59.16 ± 0.67 17.66 ± 0.10 29.94 ± 0.18 825.00 ± 57.48 0.14 ± 0.00 
All the values are expressed as the mean ± SEM. G1: Normal control; G2: Disease control; G3: Reference item (Levamisole); G4: Biofield Energy Treated test 
formulation; G5: Untreated test formulation. 
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3.4. Effect of the Test Formulation on Biochemistry 
Parameters 
The effect of the test formulation on different biochemical 
parameters is shown in the Table 3. The level of phosphorus 
was significantly increased by 11.16%, 16.35%, and 23.54% 
in the levamisole (G3), Biofield Energy Treated test 
formulation (G4), and untreated test formulation group (G5), 
respectively compared to the G2 group. The results might be 
due to the positive effect of the Biofield Energy Healing to 
the novel herbomineral product, which could be very helpful 
to the patients in the near future. Besides, the levels of 
magnesium, blood area, creatinine, uric acid, calcium, and 
ions like sodium, potassium, and chloride were altered in all 
the tested groups to some extent but did not show any 
significant difference with respect to the disease control 
group (G2). Altogether, on the assessment of serum 
chemistry profile exhibited a significant increased the level 
of serum phosphorus in the Biofield Energy Treated test 
formulation group (G4) compared to the G2 group. 
Table 3. Estimation of biochemical parameters after the treatment with the test formulation in experimental rats. 
Group 
Magnesium 
(mg/dL) 
Blood Urea 
(mg/dL) 
Creatinine 
(mg/dL) 
Uric Acid 
(mg/dL) 
Calcium 
(mg/dL) 
Phosphorus 
(mg/dL) 
Na+ (Meq/L) 
K+ 
(mEq/L) 
Cl- (mEq/L) 
G1 6.30 ± 0.02 26.99 ± 1.42 0.30 ± 0.02 0.75 ± 0.11 10.06 ± 0.13 9.64 ± 0.28 151.03 ± 0.85 5.04 ± 0.10 110.88 ± 6.32 
G2 6.32 ± 0.02 31.85 ± 1.83 0.29 ± 0.01 0.69 ± 0.13 9.59 ± 0.18 9.05 ± 0.15 151.04 ± 0.86 5.19 ± 0.14 105.25 ± 0.88 
G3 6.35 ± 0.02 35.40 ± 2.24 0.69 ± 0.28 0.71 ± 0.12 10.35 ± 0.27 10.06 ± 0.23 150.21 ± 0.25 4.99 ± 0.09 107.75 ± 1.81 
G4 6.32 ± 0.02 32.78 ± 0.66 0.30 ± 0.01 0.83 ± 0. 16 9.85 ± 0.11 10.53 ± 0.25 152.09 ± 1.02 5.19 ± 0.11 106.06 ± 1.41 
G5 6.34 ± 0.02 32.13 ± 1.65 0.29 ± 0.01 0.65 ± 0.08 9.89 ± 0.12 11.18 ± 0.22 151.94 ± 1.01 5.21 ± 0.12 108.00 ± 1.60 
All the values are expressed as the mean ± SEM. G1: Normal control; G2: Disease control; G3: Reference item (Levamisole); G4: Biofield Energy Treated test 
formulation; G5: Untreated test formulation. 
3.5. Effect of the Test Formulation on Body Weight and 
Organ to Body Weight Ratio 
The results of animal weight parameters such as animal 
body weight, and respective organ weight obtained after oral 
administration of the test formulation are summarized in the 
Table 4. The initial mean body weight was 269.51 ± 5.53, 
269.92 ± 3.56, 271.52 ± 4.94, 270.21 ± 3.76, and 269.43 ± 
3.40 gm from group G1 to G5, respectively. However, final 
body weight in all the group were increased i.e. 385.69 ± 
7.53, 351.20 ± 6.60, 321.27 ± 10.10, 336.42 ± 12.27, and 
356.63 ± 5.91 gm from group G1 to G5, respectively. Thus, 
overall data of body weight analysis visualized no significant 
change in body weight with respect to the disease control 
group, it suggest that the test formulation was found to be 
safe in all the tested animal groups. 
Table 4. Effect of the test formulation on various vital organs in male Sprague Dawley rats. 
Relative organ weight (%) G1 G2 G3 G4 G5 
Liver 3.71 ± 0.14 4.08 ± 0.13 4.79 ± 0.15 4.27 ± 0.11 4.52 ± 0.10 
Lungs 0.65 ± 0.06 0.96 ± 0.07 1.04 ± 0.10 0.84 ± 0.05 0.92 ± 0.04 
Kidneys 0.90 ± 0.05 0.90 ± 0.02 1.04 ± 0.02 0.94 ± 0.02 0.93 ± 0.02 
Brain 0.59 ± 0.01 0.64 ± 0.02 0.71 ± 0.03 0.67 ± 0.03 0.62 ± 0.02 
Heart 0.38 ± 0.01 0.44 ± 0.01 0.43 ± 0.02 0.44 ±0.02 0.42 ± 0.02 
Eyes 0.07 ± 0.00 0.08 ± 0.00 0.09 ± 0.00 0.09 ± 0.00 0.08 ± 0.00 
Spleen 0.22 ± 0.01 0.24 ± 0.01 0.21 ± 0.01 0.20 ± 0.01 0.22 ± 0.02 
Pancreas 0.71 ± 0.08 0.63 ± 0.02 0.68 ± 0.04 0.60 ± 0.05 0.65 ± 0.04 
Duodenum 0.24 ± 0.01 0.29 ± 0.02 0.37 ± 0.02 0.39 ± 0.03 0.37 ± 0.02 
Jejunum 1.42 ± 0.05 1.64 ± 0.11 1.74 ± 0.06 1.90 ± 0.10 1.91 ± 0.11 
Ileum 0.31 ± 0.02 0.34 ± 0.02 0.34 ± 0.02 0.45 ± 0.03 0.46 ± 0.05 
Caecum 0.53 ± 0.03 0.51 ± 0.03 0.56 ± 0.04 0.64 ± 0.03 0.53 ± 0.03 
Colon 0.33 ± 0.02 0.40 ± 0.02 0.50 ± 0.02 0.37 ± 0.02 0.41 ± 0.01 
Rectum 0.14 ± 0.01 0.20 ± 0.01 0.20 ± 0.02 0.19 ± 0.01 0.18 ± 0.02 
Testis 0.98 ± 0.03 1.11 ± 0.05 1.16 ± 0.04 1.17 ± 0.07 1.03 ± 0.05 
Prostate 0.18 ± 0.01 0.22 ± 0.02 0.20 ± 0.03 0.21 ± 0.01 0.19 ± 0.01 
Epididymis 0.33 ± 0.01 0.38 ± 0.02 0.36 ± 0.01 0.35 ± 0.04 0.35 ± 0.02 
Vas deference 0.07 ± 0.00 0.07 ± 0.00 0.08 ± 0.00 0.08 ± 0.01 0.06 ± 0.00 
All the values are expressed as the mean ± SEM. G1: Normal control; G2: Disease control; G3: Reference item (Levamisole); G4: Biofield Energy Treated test 
formulation; G5: Untreated test formulation. 
The relative organ weight is a useful index for the 
identification of swelling, atrophy or hypertrophy [50]. The 
increase organ to body weight ratio might be correlated with 
the sign of product toxicity, but the experimental results 
suggested that there was not much change in most of the vital 
organs, which depicts that the test formulation was non-toxic 
to the animals throughout the exposure period (23 days) at 
the dose rate of 1105.005 mg/kg. 
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3.6. Assessment of Animal Feed and Water Intake 
The results of animal feed and water intake are presented 
as mean values throughout the study period in the Table 5. 
There was no significant alteration observed in the feed 
intake in all the groups. The water intake was gradually 
increased in across to all the groups as shown in Table 5. 
These findings suggest that there was no significant changes 
observed in terms of feed intake and water intake. Based on 
these results, it can be inferred that the oral administration of 
Biofield Energy Treated test formulation was found to be 
safe. 
Table 5. The effect of the test formulation on feed intake and water intake in male Sprague Dawley rats. 
Group 
Feed Intake (g) Water intake (mL) 
Initial Final Initial Final 
G1 24.18 ± 0.93 27.35 ± 0.57 35.10 ± 2.22 45.33 ± 2.22 
G2 21.94 ± 0.76 27.80 ± 0.70 32.72 ± 1.76 44.67 ± 2.23 
G3 17.84 ± 1.12 24.13 ± 0.42 31.72 ± 2.48 45.91 ± 2.45 
G4 21.83 ± 0.83 25.81 ± 0.77 35.48 ± 2.30 46.23 ± 1.97 
G5 21.59 ± 0.92 27.61 ± 0.71 34.56 ± 1.91 42.66 ± 1.88 
All the values are expressed as mean ± SEM (n=8). G1: Normal control; G2: Disease control; G3: Reference item (Levamisole); G4: Biofield Energy Treated 
test formulation; G5: Untreated test formulation. 
3.7. Assessment of Histopathological Examination 
The effect of the test formulation on histopathological findings in male SD rats is shown in Figure 2. No significant 
differences were observed either in gross and microscopic observation of the tested organs. Histopathological findings suggest 
that no Biofield Energy Healing related histopathological changes were observed in all the experimental animals compared 
with the normal control group. 
 
Figure 2. Histopathological photomicrograph of major organs of male Sprague Dawley rats. All the tissues were sectioned transversely and stained with 
hematoxylin and eosin. G1: Normal control; G2: Disease control; G3: Levamisole; G4: Biofield Energy Treated test formulation; G5: Untreated test 
formulation. 
The National Center for Complementary/Alternative 
Medicine (NCCAM,) reported that about 34% U.S. 
populations depends on some forms of complementary health 
approach, among which energy medicine is one of them. 
CAM has huge positive aspect as compared to the 
conventional treatment strategy [51]. Overall study findings 
envisaged that the novel herbomineral formulation could be 
anti-inflammatory and immunomodulatory effect and might 
produce as a better immunomodulatory medicine in the near 
future. Although the herbomineral formulation could be 
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beneficial due to the combination of multiple compounds, 
which might have synergetic effect along with minimal side-
effect of the constituent. Therefore, it is assumed that the 
Biofield Energy Treated herbomineral formulation might be 
considered as a safe dietary supplement and more powerfull 
product for boosting the immunity in healthy human and 
patient. 
4. Conclusions 
Results of our study revealed that, the humoral immune 
response of both the primary and secondary 
hemagglutination (HA) antibody titre levels were 
significantly altered by 14.79% and 12.89%, respectively in 
the Biofield Energy Treated test formulation group (G4) 
compared to the disease control group (G2). The delayed 
type hypersensitivity (DTH) response was significantly 
(p≤0.05) increased by 55.56% in the G4 group compared to 
the G2 group. Besides, the platelet count was significantly 
increased by 8.46% in the G4 group with respect to the G2 
group. The level of phosphorus was significantly increased 
by 11.16% in the G4 group compared to the G2 group. 
Further, no treatment-related changes were observed in the 
G4 group with respect to the body weight, feed consumption 
and water intake, relative organ weight, and histopathological 
findings during the course of the experiment. Overall, the 
change in above weight parameters were consistent 
throughout the study, which suggest that the Biofield Energy 
Treated test formulation has safe nutritional status with 
respect to the physiological and metabolic changes. 
Therefore, the current findings conclude The Trivedi 
Effect
®
-Biofield Energy Healing administered remotely by 
the twenty Biofield Energy Healers enhanced the 
herbomineral test formulation’s anti-inflammatory and 
immunomodulatory properties without any side effect, which 
can be used as a herbomineral product to improve the overall 
health. Thus, the Biofield Energy Treated test formulation 
may act as an effective anti-inflammatory and 
immunomodulatory product, and it can be used as a 
Complementary and Alternative Medicine (CAM) with a safe 
therapeutic index for various autoimmune disorders such as 
Lupus, Systemic Lupus Erythematosus, Fibromyalgia, 
Addison Disease, Hashimoto Thyroiditis, Celiac Disease 
(gluten-sensitive enteropathy), Multiple Sclerosis, 
Dermatomyositis, Graves’ Disease, Myasthenia Gravis, 
Pernicious Anemia, Aplastic Anemia, Scleroderma, 
Psoriasis, Rheumatoid Arthritis, Reactive Arthritis, Type 1 
Diabetes, Sjogren Syndrome, Crohn’s Disease, Vasculitis, 
Vitiligo, Chronic Fatigue Syndrome and Alopecia Areata, as 
well as inflammatory disorders such as Irritable Bowel 
Syndrome (IBS), Asthma, Ulcerative Colitis, Alzheimer’s 
Disease, Parkinson’s Disease, Atherosclerosis, Dermatitis, 
Hepatitis, and Diverticulitis. Further, the Biofield Energy 
Healing Treated test formulation can also be used in the 
prevention of immune-mediated tissue damage in cases of 
organ transplants (for example heart transplants, kidney 
transplants and liver transplants), for anti-aging, stress 
prevention and management, and in the improvement of 
overall health and quality of life. 
Acknowledgements 
The authors are grateful to Dabur Research Foundation, 
Trivedi Science, Trivedi Global, Inc., and Trivedi Master 
Wellness for their support throughout the work. 
 
References 
[1] Phillipson JD (1994) Natural products as drugs. Trans Royal 
Soc Trop Med Hyg 88: S17-S19. 
[2] Khan S, Balick MJ (2001) Therapeutic plants of Ayurveda: A 
review of selected clinical and other Studies for 166 Species. J 
Altern Complement Med 7: 405-515. 
[3] Patwardhan B, Chorghade M (2004) Ayurveda and natural 
products drug discovery. Curr Sci 86: 789-798. 
[4] Patel P, Basheeruddin Asdaq SM (2010) Immunomodulatory 
activity of methanolic fruit extract of Aegle marmelos in 
experimental animals. Saudi Pharm J 18: 161-165. 
[5] Heroor S, Beknal A, Mahurkar N (2012) Preliminary 
investigation for immunomodulation of methanolic extracts of 
leaves and flowers of Pongamia glabra Vent. in mice model. 
Adv Lif Sci 2: 170-173. 
[6] Farhath S, Vijaya PP, Vima M (2013) Immunomodulatory 
activity of geranial, geranial acetate, gingerol, and eugenol 
essential oils: Evidence for humoral and cell-mediated 
responses. Avicenna J Phytomed 3: 224-230. 
[7] MacLennan AH, Wilson DH, Taylor AW (1996) Prevalence 
and cost of alternative medicine in Australia. Lancet 347: 569 
- 573. 
[8] Houston M (2014) The role of nutrition and nutraceutical 
supplements in the treatment of hypertension. World J Cardiol 
6: 38-66. 
[9] Bishop WM, Zubeck HM (2012) Evaluation of microalgae for 
use as nutraceuticals and nutritional supplements. J Nutr Food 
Sci 2: 147. 
[10] Houston M (2013) Nutrition and nutraceutical supplements for 
the treatment of hypertension: Part I. J Clin Hypertens 
(Greenwich) 15: 752-757. 
[11] Qureshi NA, Al-Bedah AM (2013) Mood disorders and 
complementary and alternative medicine: A literature review. 
Neuropsychiatr Dis Treat 9: 639-658. 
[12] Lutgendorf SK, Mullen-Houser E, Russell D, Degeest K, 
Jacobson G, Hart L, Bender D, Anderson B, Buekers TE, 
Goodheart MJ, Antoni MH, Sood AK, Lubaroff DM (2010) 
Preservation of immune function in cervical cancer patients 
during chemoradiation using a novel integrative approach. 
Brain, behavior, and immunity 24: 1231-1240. 
[13] Ironson G, Field T, Scafidi F, Hashimoto M, Kumar M, 
Kumar A, Price A, Goncalves A, Burman I, Tetenman C, 
Patarca R, Fletcher MA (1996) Massage therapy is associated 
with enhancement of the immune system's cytotoxic capacity. 
Int J Neurosci 84: 205-217. 
 American Journal of Health Research 2017; 5(6): 183-192 191 
 
[14] Koithan M (2009) Introducing complementary and alternative 
therapies. J Nurse Pract 5: 18-20. 
[15] Jain S, Hammerschlag R, Mills P, Cohen L, Krieger R, Vieten 
C, Lutgendorf S (2015) Clinical studies of biofield therapies: 
Summary, methodological challenges, and recommendations. 
Glob Adv Health Med 4: 58-66. 
[16] Rubik B (2002) The biofield hypothesis: Its biophysical basis 
and role in medicine. J Altern Complement Med 8: 703-717. 
[17] Trivedi MK, Patil S, Shettigar H, Mondal SC, Jana S (2015) 
The potential impact of biofield treatment on human brain 
tumor cells: A time-lapse video microscopy. J Integr Oncol 4: 
141. 
[18] Trivedi MK, Patil S, Shettigar H, Gangwar M, Jana S (2015) 
In vitro evaluation of biofield treatment on cancer biomarkers 
involved in endometrial and prostate cancer cell lines. J 
Cancer Sci Ther 7: 253-257. 
[19] Trivedi MK, Patil S, Shettigar H, Mondal SC, Jana S (2015) 
In vitro evaluation of biofield treatment on Enterobacter 
cloacae: Impact on antimicrobial susceptibility and biotype. J 
Bacteriol Parasitol 6: 241. 
[20] Trivedi MK, Patil S, Shettigar H, Mondal SC, Jana S (2015) 
Evaluation of biofield modality on viral load of hepatitis B 
and C Viruses. J Antivir Antiretrovir 7: 083-088. 
[21] Trivedi MK, Patil S, Shettigar H, Mondal SC, Jana S (2015) 
An impact of biofield treatment: Antimycobacterial 
susceptibility potential using BACTEC 460/MGIT-TB 
System. Mycobact Dis 5: 189. 
[22] Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, 
Jana S (2015) Antimicrobial sensitivity, biochemical 
characteristics and biotyping of Staphylococcus 
saprophyticus: An impact of biofield energy treatment. J 
Women’s Health Care 4: 271. 
[23] Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, 
Jana S (2015) Evaluation of antibiogram, genotype and 
phylogenetic analysis of biofield treated Nocardia otitidis. 
Biol Syst Open Access 4: 143. 
[24] Trivedi MK, Branton A, Trivedi D, Nayak G, Charan S, Jana 
S (2015) Phenotyping and 16S rDNA analysis after biofield 
treatment on Citrobacter braakii: A urinary pathogen. J Clin 
Med Genom 3: 129. 
[25] Trivedi MK, Patil S, Shettigar H, Bairwa K, Jana S (2015) 
Spectroscopic characterization of chloramphenicol and 
tetracycline: An impact of biofield. Pharm Anal Acta 6:395. 
[26] Trivedi MK, Patil S, Shettigar H, Bairwa K, Jana S (2015) 
Spectroscopic characterization of biofield treated 
metronidazole and tinidazole. Med Chem 5: 340-344. 
[27] Trivedi MK, Patil S, Shettigar H, Bairwa K, Jana S (2015) 
Effect of biofield treatment on spectral properties of 
paracetamol and piroxicam. Chem Sci J 6: 98. 
[28] Trivedi MK, Branton A, Trivedi D, Shettigar H, Bairwa K, 
Jana S (2015) Fourier transform infrared and ultraviolet-
visible spectroscopic characterization of biofield treated 
salicylic acid and sparfloxacin. Nat Prod Chem Res 3: 186. 
[29] Trivedi MK, Branton A, Trivedi D, Nayak G, Gangwar M, 
Jana S (2016) Molecular analysis of biofield treated eggplant 
and watermelon crops. Adv Crop Sci Tech 4: 208. 
[30] Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, 
Jana S (2015) Morphological characterization, quality, yield 
and DNA fingerprinting of biofield energy treated alphonso 
mango (Mangifera indica L.). Journal of Food and Nutrition 
Sciences 3: 245-250. 
[31] Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, 
Jana S (2015) Evaluation of plant growth, yield and yield 
attributes of biofield energy treated mustard (Brassica juncea) 
and chick pea (Cicer arietinum) seeds. Agriculture, Forestry 
and Fisheries 4: 291-295. 
[32] Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, 
Jana S (2015) Evaluation of plant growth regulator, immunity 
and DNA fingerprinting of biofield energy treated mustard 
seeds (Brassica juncea). Agriculture, Forestry and Fisheries 4: 
269-274. 
[33] Trivedi MK, Tallapragada RM, Branton A, Trivedi D, Nayak 
G, Jana S (2015) Characterization of physical and structural 
properties of aluminum carbide powder: Impact of biofield 
treatment. J Aeronaut Aerospace Eng 4: 142. 
[34] Trivedi MK, Nayak G, Patil S, Tallapragada RM, Latiyal O, 
Jana S (2015) Impact of biofield treatment on atomic and 
structural characteristics of barium titanate powder. Ind Eng 
Manage 4: 166. 
[35] Trivedi MK, Patil S, Nayak G, Jana S, Latiyal O (2015) 
Influence of biofield treatment on physical, structural and 
spectral properties of boron nitride. J Material Sci Eng 4: 181. 
[36] Trivedi MK, Nayak G, Patil S, Tallapragada RM, Latiyal O, 
Jana S (2015) Characterization of physical and structural 
properties of brass powder after biofield treatment. J Powder 
Metall Min 4: 134. 
[37] Ladics GS (2007) Primary immune response to sheep red 
blood cells (SRBC) as the conventional T-cell dependent 
antibody response (TDAR) test. J Immunotoxicol 4: 149-152. 
[38] Joharapurkar AA, Zambad SP, Wanjari MM, Umathe SN 
(2003) In vivo evaluation of antioxidant activity of alcoholic 
extract of Rubia cordifolia Linn. and its influence on ethanol-
induced immunosuppression. Indian J Pharmacol 35: 232-236. 
[39] Nelson DS, Mildenhall P (1967) Studies on cytophilic 
antibodies. 1. The production by mice of macrophage 
cytophilic antibodies to sheep erythrocytes: relationship to the 
production of other antibodies and the development of 
delayed-type hypersensitivity. Aust J Exp Biol Med Sci 45: 
113-130. 
[40] Saiki I, Tanio Y, Yamawaki M, Uemiya M, Kobayashi S, 
Fukuda T, Yukimasa H, Yamamura Y, Azuma I (1981) 
Adjuvant activities of quinonyl-N-acetyl muramyl dipeptides 
in mice and guinea pigs. Infect Immun 31: 114-121. 
[41] Feldman BF, Zinkl JG, Jain VC. Laboratory techniques for 
avian hematology,” in Schalm’s Veterinary Hematology, (5th 
Edn) Lippincott Williams & Wilkins, Toronto, Canada, 2000. 
[42] Chanda S, Dave R, Kaneria M, Shukla V (2012) Acute oral 
toxicity of Polyalthia longifolia var. pendula leaf extract in 
wistar albino rats. Pharm Biol 50: 1408-1415. 
[43] OECD, OECD Guideline for Testing of Chemicals, vol. 420, 
Organization for Economic Cooperation and Development, 
Paris, France, 1992. 
192 Mahendra Kumar Trivedi et al.:  Immunomodulatory Activity of Biofield Energy Healing Based Herbomineral Formulation in   
Sprague Dawley Rats: Evidence for Humoral and Cell-Mediated Responses 
[44] Sellers RS, Morton D, Michael B, Roome N, Johnson JK, 
Yano B, Perry R, Schafer K (2007) Society of toxicologic 
pathology position paper: Organ weight recommendations for 
toxicology studies. Toxicol Pathol 35: 751-755. 
[45] Bailey SA, Zidell RH, Perry RW (2004) Relationships 
between organ weight and body/brain weight in the rat: What 
is the best analytical endpoint? Toxicol Pathol 32: 448-466. 
[46] Naik SR, Gavankar C, Thakare VN (2015) 
Immunomodulatory activity of Withania somnifera and 
Curcuma longa in animal models: Modulation of cytokines 
functioning. Pharmacologia 6: 168-177. 
[47] Nagalakshmi D, Sridhar K, Parashuramulu S (2015) 
Replacement of inorganic zinc with lower levels of organic 
zinc (zinc nicotinate) on performance, hematological and 
serum biochemical constituents, antioxidants status and 
immune responses in rats. Vet World 8: 1156-1162. 
[48] Agarwal R, Diwanay S, Patki P, Patwardhan B (1999) Studies 
on immunomodulatory activity of Withania somnifera 
(ashwagandha) extracts in experimental immune 
inflammation. J Ethnopharmacol 67: 27-35. 
[49] Ziauddin M, Phansalkar N, Patki P, Diwanay S, Patwardhan B 
(1996) Studies on immunomodulatory effects of a 
ashwagandha. J Ethnopharmacol 50: 69-76. 
[50] Amresh GR, Singh PN, Rao CV (2008) Toxicological 
screening of traditional medicine Laghupatha (Cissampelos 
pareira) in experimental animals. J Ethnopharmacol 116: 454-
460. 
[51] Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL 
(2015) Trends in the use of complementary health approaches 
among adults: Unites States, 2002-2012. National health 
statistics reports. no 79. Hyattsville, MD: National Center for 
Health Statistics. 
 
